TY  - GEN
AB  - This book provides a wealth of images and extensive information on circulating tumor cells (CTCs) and other cells usually observed in blood from patients with cancer, such as giant macrophages, and circulating tumor microemboli (CTM). The field of liquid biopsy began with the analysis of CTCs in the early 2000s. In the beginning, molecular techniques were developed to detect these cells in the blood. However, it has since become clear that CTCs initially require a cytopathological analysis to be detected without false positive and negative results. After detection, molecular analysis can be subsequently performed. Cancer is an important cause of mortality, especially when detected in late stages. Even with all the advances that have been made in its treatment, cancer is still challenging, as many patients do not respond to any therapy. Many health agencies have considered early diagnosis as a feasible tool. In this context, it is of the utmost importance to know the morphology and characteristics of CTCs to determine a correct diagnosis. Currently much of the scientific community is committed to expanding our knowledge of CTCs, and this work makes a valuable contribution, presenting many cell images from patients with several types of cancer, in different stages of disease, and after receiving various treatments. The Atlas of Liquid Biopsy: Circulating Tumor Cells and Other Rare Cells in Cancer Patients Blood is an essential reference guide for all physicians, biologists, biomedics, and professionals working at hospitals, clinics and research centers.
AU  - Chinen, Ludmilla Thomé Domingos,
CN  - RB43
DO  - 10.1007/978-3-030-69879-9
DO  - doi
ID  - 1437043
KW  - Cytodiagnosis
KW  - Tumor markers
KW  - Cytodiagnostics
KW  - Marqueurs tumoraux
LK  - https://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-69879-9
N2  - This book provides a wealth of images and extensive information on circulating tumor cells (CTCs) and other cells usually observed in blood from patients with cancer, such as giant macrophages, and circulating tumor microemboli (CTM). The field of liquid biopsy began with the analysis of CTCs in the early 2000s. In the beginning, molecular techniques were developed to detect these cells in the blood. However, it has since become clear that CTCs initially require a cytopathological analysis to be detected without false positive and negative results. After detection, molecular analysis can be subsequently performed. Cancer is an important cause of mortality, especially when detected in late stages. Even with all the advances that have been made in its treatment, cancer is still challenging, as many patients do not respond to any therapy. Many health agencies have considered early diagnosis as a feasible tool. In this context, it is of the utmost importance to know the morphology and characteristics of CTCs to determine a correct diagnosis. Currently much of the scientific community is committed to expanding our knowledge of CTCs, and this work makes a valuable contribution, presenting many cell images from patients with several types of cancer, in different stages of disease, and after receiving various treatments. The Atlas of Liquid Biopsy: Circulating Tumor Cells and Other Rare Cells in Cancer Patients Blood is an essential reference guide for all physicians, biologists, biomedics, and professionals working at hospitals, clinics and research centers.
SN  - 9783030698799
SN  - 3030698793
SN  - 9783030698805
SN  - 3030698807
T1  - Atlas of liquid biopsy :circulating tumor cells and other rare cells in cancer patients' blood /
TI  - Atlas of liquid biopsy :circulating tumor cells and other rare cells in cancer patients' blood /
UR  - https://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-69879-9
ER  -